Alkermes Inc., ("Alkermes") is offering your patients the opportunity to receive free trial units of Alkermes products to facilitate prompt patient trial of the products in the inpatient hospital and crisis stabilization unit settings of care.
If you experience any difficulties with logging in or have any questions regarding your product order please contact the Alkermes Hospital or Crisis Stabilization Unit Pharmacists Customer Service Center at the following:
Alkermes Inc., ("Alkermes") is offering your patients the opportunity to receive free trial units of Alkermes products to facilitate prompt patient trial of the products in the inpatient hospital and crisis stabilization unit settings of care.
The Alkermes® Hospital Inpatient Free Trial Program is available only to inpatient hospital and crisis stabilization unit pharmacies that do not accept PDMA compliant drug samples and are validly licensed under applicable state law. Additional limits may apply per institution. This program, as amended from time to time, will be available through December 31, 2025. Alkermes manufactured product is being provided free of charge. Do not separately bill the patient, the patient's insurance carrier, or any government healthcare program for any Alkermes manufactured product dispensed as part of this program. Where drug costs are included in a capitated rate or there is submission of a cost report or other insurer or government program reporting requirement, you must properly report the use of the free trial units and once reported, such information may be made publicly available. There is no requirement for any subsequent use of Alkermes manufactured product. Program available only in the United States. Alkermes, Inc. may terminate the program prior to December 31, 2025, upon 60 days notice to all participating inpatient pharmacies, or upon less or no notice if there is a change in interpretation of applicable federal or state laws.